Drug Patents owned by Chattem Sanofi
1. Drug name - CHILDREN'S ALLEGRA ALLERGY
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8933097 | CHATTEM SANOFI | Fexofenadine suspension formulation |
Aug, 2030
(7 years from now) | |
Drugs and Companies using FEXOFENADINE HYDROCHLORIDE ingredient
Treatment: NA
Dosage: SUSPENSION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 30MG/5ML | SUSPENSION;ORAL | Discontinued |
2. Drug name - XYZAL ALLERGY 24HR
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US8633194 | CHATTEM SANOFI | Pharmaceutical composition of piperazine derivatives |
Oct, 2027
(5 years from now) | |
Drugs and Companies using LEVOCETIRIZINE DIHYDROCHLORIDE ingredient
Treatment: NA
Dosage: SOLUTION;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 2.5MG/5ML | SOLUTION;ORAL | Over the counter |
availability in other generic markets.
Click on the highlighted region to filter.